Click the button in the upper right corner to open the directory menu
The jury of Internet+ and Challenge Cup
In May and June 2020, after completing the business plan, we tried to use synthetic biology to create a comprehensive solution for pulmonary fibrosis. The jury of Internet+
and Challenge Cup put forward more practical suggestions for the commercialization of our products. We need to independently develop technology research and development and
authorize OEM production to address the market pain points of high price and poor efficacy of existing therapies in the pulmonary fibrosis market. After mass production,
the products are sold and promoted in general hospitals and chronic disease rehabilitation centers, and innovation and upgrades are carried out based on patient feedback.
In July 2020, the team and Sichuan University Science and Technology Park Development Co., Ltd. signed an incubation platform entry agreement. Entering the Sichuan University
Pioneer Park can provide us with favorable conditions such as venue guarantee, entrepreneurial guidance, market promotion, affairs agency and policy implementation.
In August 2020, the team and other universities participated in the Nanjing Conference. GenScript Biotechnology Co., Ltd. put forward suggestions on the progress direction of
the project human practice, and believes that we need to innovate further in the model. Specific directions include research on the needs of patients with pulmonary fibrosis,
cost analysis of existing market drugs, and more in-depth exchanges with companies. The teacher proposed that the atomization model can use the physical model to simulate
diffusion. After the discussion in our group, we believe that we can design social street experiments to feel the breathing of patients with pulmonary fibrosis, so as to
improve the society's awareness of pulmonary fibrosis.